Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effects of Dexmedetomidine in Pediatric Open-Heart Surgery with Cardiopulmonary Bypass
TCTR20260317004Phase 3Completed
- Sponsor
- Defitra Nanda Sasmita
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by Defitra Nanda Sasmita. Primary endpoints: Cerebral oxygenation by near-infrared spectroscopy and Serum S-100B levels. Started Jul 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on TCTR20260317004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260317004.